Joshua Tarnoff

Company: NephCure Kidney International

Job title: Chief Executive Officer

Seminars:

Panel & Audience Discussion: Enhancing Diversity in CKD Clinical Trials: What is Needed, What is Working, & What is Next? 11:30 am

Explore initiatives that have increased participation of underrepresented groups in CKD clinical trials where these efforts have yielded more inclusive trial populations Discuss the importance of diverse representation in trials for generating more accurate and generalizable data ensuring that treatments are effective across all demographics Explore new and emerging methods for ensuring diverse trial participation,…Read more

day: Day Two Track 2

Revolutionizing FSGS: Addressing Proteinuria & GFR as Clinical Endpoints in FSGS Through the PARASOL Initiative 11:30 am

Explore the current challenges in identifying reliable, meaningful endpoints in FSGS clinical trials, and how the PARASOL initiative seeks to establish the relationship between short-term biomarker changes (proteinuria and GFR) and long-term outcomes Exploring how global patient registries and real-world data from diverse cohorts are informing endpoint identification, particularly in rare diseases like FSGS where…Read more

day: Pre-Conference Focus Day